Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001854471 | SCV002216952 | uncertain significance | Alzheimer disease 3; Frontotemporal dementia; Pick disease; Acne inversa, familial, 3 | 2022-06-27 | criteria provided, single submitter | clinical testing | Experimental studies have shown that this missense change affects PSEN1 function (PMID: 27930341). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PSEN1 protein function. ClinVar contains an entry for this variant (Variation ID: 98008). This missense change has been observed in individual(s) with early-onset Alzheimer disease (PMID: 11568920). This variant is present in population databases (rs63750831, gnomAD 0.003%). This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 94 of the PSEN1 protein (p.Val94Met). |
VIB Department of Molecular Genetics, |
RCV000084287 | SCV000116423 | not provided | not provided | no assertion provided | not provided |